Amesite Inc (AMST) Q3 2024 Earnings Report

Amesite reported Q3 2024 (calendar year 2024, period ended 2024-03-31) with a pronounced revenue shortfall and a continued operating loss. Revenue was $34,261 vs. $- a fraction of prior periods, yielding a gross loss of $87,891 and a gross margin of -256.5% (reported as -2.57% in the data). Operating expenses remained elevated at $1.376 million, driving an EBITDA of -$1.303 million and an operating income of -$1.463 million. Net income totaled -$1.426 million, or -$0.56 per share on a diluted basis, underscoring a persistently negative bottom line. In the quarter, management incurred meaningful non-cash charges (stock-based compensation of $672k, depreciation & amortization of $122k) and a modest working capital swing, contributing to a negative operating cash flow of -$0.582 million. Free cash flow was -$0.691 million, and the company ended the quarter with cash and equivalents of $2.97 million, net of cash used in operations and investing activities. The balance sheet shows a solid liquidity position with a current ratio of 14.89 and net cash positioning (no long-term debt reported), yet profitability remains elusive as the company continues to invest in R&D and go-to-market initiatives. Year-over-year and quarter-over-quarter comparisons reflect a steep revenue decline (YoY: -83.25%; QoQ: -17.33%) and a dramatic deterioration in gross profit (YoY: -312.82%; QoQ: +10.52% in gross profit margin, indicating a minor QoQ improvement in gross profitability despite a negative absolute gross figure). Given the scale of the business and the current cash burn, the near-term focus appears to be on revenue acceleration and expense discipline to achieve a path toward sustainable profitability. This report assesses the implications for investors, including an investment outlook under current trajectories and potential catalysts.